Trial
NCT02072226
A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Stroke
Intervention
Alteplase
Why stopped
The study was terminated due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-03